- Home
- CANG vs SION Comparison
CANG vs SION Comparison
Compare CANG & SION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CANG
- SION
- Stock Information
- Founded
- CANG 2010
- SION 2019
- Country
- CANG China
- SION United States
- Employees
- CANG N/A
- SION N/A
- Industry
- CANG Computer Software: Prepackaged Software
- SION
- Sector
- CANG Technology
- SION
- Exchange
- CANG Nasdaq
- SION NYSE
- Market Cap
- CANG 370.5M
- SION 338.0M
- IPO Year
- CANG 2018
- SION 2025
- Fundamental
- Price
- CANG $3.73
- SION $11.07
- Analyst Decision
- CANG
- SION Strong Buy
- Analyst Count
- CANG 0
- SION 1
- Target Price
- CANG N/A
- SION $32.00
- AVG Volume (30 Days)
- CANG 235.0K
- SION 225.5K
- Earning Date
- CANG 06-11-2025
- SION 05-25-2025
- Dividend Yield
- CANG N/A
- SION N/A
- EPS Growth
- CANG N/A
- SION N/A
- EPS
- CANG 0.35
- SION N/A
- Revenue
- CANG $110,217,499.00
- SION N/A
- Revenue This Year
- CANG N/A
- SION N/A
- Revenue Next Year
- CANG N/A
- SION N/A
- P/E Ratio
- CANG $10.55
- SION N/A
- Revenue Growth
- CANG N/A
- SION N/A
- 52 Week Low
- CANG $1.32
- SION $7.26
- 52 Week High
- CANG $9.66
- SION $25.19
- Technical
- Relative Strength Index (RSI)
- CANG 48.73
- SION N/A
- Support Level
- CANG $3.49
- SION N/A
- Resistance Level
- CANG $3.90
- SION N/A
- Average True Range (ATR)
- CANG 0.33
- SION 0.00
- MACD
- CANG -0.00
- SION 0.00
- Stochastic Oscillator
- CANG 51.00
- SION 0.00
About CANG Cango Inc. each representing two (2)
Cango Inc through its subsidiaries, variable interest entities (VIEs), and subsidiaries of the VIEs, are principally engaged in bitcoin mining business, and the automobile trading transaction, automotive financing facilitation, and aftermarket service facilitation businesses (collectively, the automobile and related businesses). The Company conducts the bitcoin mining business mainly through its subsidiaries, and the automobile and related businesses are conducted through the Company's VIEs and the subsidiaries of the VIEs. The company derives majority of its revenue from the bitcoin mining business.
About SION SIONNA THERAPEUTICS INC
Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.